The HER2 growth-factor gene is known to be over-active in breast and gastro-esophageal cancers. But now, irregularities in the genes' expression -- among them mutations, amplifications, substitutions, and translocations -- have been found in 14 different advanced solid tumors.
Fuente : http://www.eurekalert.org/pub_releases/2013-06/tju...
Fuente : http://www.eurekalert.org/pub_releases/2013-06/tju...